Skip to main content

Oncology Startups

Updated July 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 300 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
300
Total Funding
$982.5M
Avg Funding
$39.3M
Global Reach
9
countries

Top Cities for Oncology

Palo Alto
Phoenix
Minnesota City
Edinburgh
São Paulo
Vancouver

Recently Funded Companies

Export
Palo Alto, United States

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

$25.0M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Phoenix, United States

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

$60.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Minnesota City, United States

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

$9.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Edinburgh, United Kingdom

Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours for cancer research

$5.3M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

São Paulo, Brazil

Comsentimento enriches and connects data to improve care and accelerate cancer research.

$286K raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Vancouver, Canada

Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.

$1.5M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Brooklyn, United States

Epi One aims to take early cancer diagnosis to the next level by leveraging a novel epigenetic biomarker platform.

$2.1M raised
Dec 2024

Founder Contacts

30,000+ verified contacts

Mechelen, Belgium

ElmediX is a provider of cancer treatment.

$4.5M raised
Jan 2022

Founder Contacts

30,000+ verified contacts

Kirkland, United States

Aminex Therapeutics develops small molecule based cancer treatment solutions.

$15.1M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

$150.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

San Carlos, United States

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

$2.8M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Calgary, Canada

Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.

$886K raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Carlsbad, United States

View Point Medical is a medical device and technology company developing tissue markers that enable lesion localization in cancer care.

$3.8M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Bellaire, United States

Oncology Health Partners provides oncology care coordination, clinical support, and treatment delivery services for cancer patients.

$15.0M raised
Dec 2024

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Launchpad Therapeutics operates as an antibody-focused precision oncology company.

$10.0M raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Geleen, The Netherlands

Temple Therapeutics creates and develops therapies for orthopedics, oncology, and endometriosis patients.

$325K raised
Dec 2023

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Trial Library is an oncology clinical trials company.

$10.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Prague, Czech Republic

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

$316.6M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

New York, United States

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

$14.4M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

London, United Kingdom

VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.

Dec 2022

Founder Contacts

30,000+ verified contacts

Würzburg, Germany

T-CURX develops personalized T cell therapies for cancer, leveraging a proprietary platform for improved patient outcomes.

$20.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

New York, United States

Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.

$37.0M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Lyon, France

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

$19.9M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Erasca is a developer of oncology drugs intended to provide precision oncology options.

$258.8M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Cheshunt, United Kingdom

HQ Science is a biotechnology company at the forefront of molecular diagnostics innovation.

$264K raised
Dec 2024

Founder Contacts

30,000+ verified contacts

Showing 226 to 250 of 300 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 300 oncology companies tracked in the VCBacked database.

Average Funding
$39.3M
Total Funding Tracked
$982.5M
Countries Represented
9

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.San Francisco
2 companies$20.0M
2.New York
2 companies$51.4M
3.Palo Alto
1 companies$25.0M
4.Phoenix
1 companies$60.0M
5.Minnesota City
1 companies$9.0M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

300 Oncology Startups (2026) — Recently Funded Companies, Investors & Rounds | VCBacked